Required for US and Japanese stocks. A-shares and HK stocks work without a key.
DeepSeek R1 provides high-quality analysis at very low cost. Serper provides real-time search data for context.
King International Investment Limited, an investment holding company, provides genetic testing and health data analysis services in the People's Republic of China and Hong Kong. The company operates through two segments, Healthcare Products and Services Business, and Money Lending Business. The company also engages in money lending activities. In addition, it provides corporate administrative and healthcare services. The company was formerly known as Life Healthcare Group Limited and changed its name to King International Investment Limited in December 2023. King International Investment Limited was incorporated in 2001 and is based in Central, Hong Kong.
交易所：HKG。行业板块：Healthcare。细分行业：Diagnostics & Research。最新股价：HK$0.07。本页提供 King International Investment Limited 的 DCF 现金流折现估值、相对估值历史分位、多维财务评分与 AI 辅助分析。
Required for US and Japanese stocks. A-shares and HK stocks work without a key.
DeepSeek R1 provides high-quality analysis at very low cost. Serper provides real-time search data for context.